To determine the significance of CD62L in patients with NAFLD and NASH, we measured serum levels of the soluble form of CD62L (sCD62L) in control patients, patients with NASH and NAFLD patients. The gene discussed is SELL; the disease is metabolic dysfunction-associated steatotic liver disease.